MedPath

A clinical trial to study the effects of two drugs, Diclofenac and Ketoprofen, which are used to reduce pain in postoperative upper limb orthopedic surgeries

Phase 3
Not yet recruiting
Conditions
Acute pain, not elsewhere classified, (2) ICD-10 Condition: M968||Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified,
Registration Number
CTRI/2022/12/047868
Brief Summary

Post operative pain (POP) is a critical aspect after any surgery manifesting in 70-75% of patients as moderate to severe pain. Its management is an important public health concern worldwide, especially following orthopaedic surgery. The upper limb orthopaedic surgeries which include both bone and soft tissue, should have an appropriate analgesic modality to reduce delayed post operative function which increases the duration of hospital stay and occurrence of re-admission which impacts the socio-economic and quality of life of the patients.

Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the commonly used drugs for POP relief throughout the world as they require less monitoring with fewer side effects. They are administered by oral, parenteral, inhalational, and transdermal routes. Transdermal patches provide prolonged and steady release of drugs with added advantage of avoiding first pass metabolism. Patient compliance is improved since it provides reduced dosage frequency with ease of administration and termination compared to oral route. Being non-invasive it allays the fear associated with parenteral routes. They are especially useful for post-op analgesia in surgeries where tissue dissection or expected pain is moderate such as upper limb fracture fixation surgeries.

Commonly used NSAIDs in this route are diclofenac and ketoprofen. Diclofenac is a relatively nonselective inhibitor of Cyclooxygenase (COX) whereas Ketoprofen is a nonselective COX and also Lipooxygenase inhibitor. This study is conducted as there is lack of data comparing the efficacy, tolerability, and cost-effectiveness of the transdermal patches of diclofenac and ketoprofen in post operative analgesia in upper limb fracture fixation surgeries.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Subjects willing to give written informed consent.
  • Adults above 18 years and below 65 years of age of either gender.
Exclusion Criteria
  • Subjects having history of heart block, bronchial asthma, bleeding disorders, on anticoagulants, active peptic ulcer disease, skin diseases, liver and kidney disorders and drug/alcohol abuse 2.
  • Pregnant and Lactating mothers 3.
  • Subjects with hypersensitivity to the study medications 4.
  • Subjects with poly trauma.
  • Subjects operated under general anaesthesia.
  • Subjects with contraindications to regional block.
  • Subjects with history of peripheral neuropathy and pre-existing nerve damage in the operative arm.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative pain assessment using Verbal Rating Scale and Numerical Rating Scale0hour, 4hour, 8hour, 12hour and 24hour postoperative period
Secondary Outcome Measures
NameTimeMethod
Timing of rescue analgesic administrationFrom the time of surgery
Need for rescue analgesicWithin the first 24hour postoperative period

Trial Locations

Locations (1)

Kempegowda Institute of Medical Sciences Hospital and Research Centre

🇮🇳

Bangalore, KARNATAKA, India

Kempegowda Institute of Medical Sciences Hospital and Research Centre
🇮🇳Bangalore, KARNATAKA, India
Dr Chethan B
Principal investigator
9066727063
chethan.bovi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.